BRIEF-Acelrx Pharmaceuticals posts results from phase 3 study of ARX-04
August 29, 2016 at 07:11 AM EDT
* Acelrx pharmaceuticals presents results from phase 3 study of ARX-04 in the emergency department at the international society for burn injuries